Prevention of suture hole bleeding using fibrin sealant: Benefits of factor XIII

被引:24
作者
Dickneite, G [1 ]
Metzner, H [1 ]
Nicolay, U [1 ]
机构
[1] Aventis Behring, D-35002 Marburg, Germany
关键词
fibrin sealant; hemostasis; factor XIII; blood loss; pig model;
D O I
10.1006/jsre.2000.5985
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. Suture hole bleeding is a frequent complication in vascular surgery. The use of fibrin sealants (FSs) during surgery is reported to reduce blood loss by enhancing hemostasis. Objectives. Using a pig vascular graft model we investigated: (1) the use of FSs in vascular surgery and measured blood loss with and without the use of FSs; (2) the effect of factor XIII in FSs on hemostasis and blood loss; and (3) the effect of increasing FS incubation time on hemostasis and blood loss. Materials and methods. During surgery, a 3-cm incision was made in the carotid artery wall. Incisions were covered with a Gore-Tex (PTFE) patch sutured with Ethicon monofil 5/0 or 3/0. The resulting suture holes were treated according to study protocol. Study 1: Nine pigs received either FS treatment (n = 5) or no treatment (n = 4). Study 2: Twenty pigs underwent bilateral surgery; right (n = 20) and left (n = 20) patches received either FS with factor XIII (FS + FXIII) or FS depleted of factor XIII (FS - FXIII). Study 3: Bilateral surgery was carried out on 24 pigs; PFTE patches secured with Ethicon 3/0 were treated with FS and allowed to polymerize for 120 s (n = 12), 180 s (n = 12), or 240 s (n = 12) or with solid support/thrombin (n = 12). Results. Study 1: Mean. blood loss was significantly lower in the FS-treated group compared with untreated controls (9.2 +/- 10.6 mL vs 178.8 +/- 125.5 mt, mean +/- SD, P = 0.016). Study 2: Significantly less blood was lost in the FS + FXIII group than in the FS - FXIII group (Delta = 9.6 mL, P = 0.02). Study 3: Blood loss was significantly higher from patches treated with solid support/thrombin compared with those treated with FS (P < 0.01). Conclusions. FSs containing factor XIII, such as Beriplast P, are effective in reducing suture hole bleeding and improving hemostasis during vascular graft procedures. The presence of factor XIII contributes to the efficacy of FSs and reduces the time to hemostasis. During vascular surgery, blood loss can be reduced significantly by the use of fibrin sealant compared with absorbable gelatin sponges coated with thrombin. (C) 2000 Academic Press.
引用
收藏
页码:201 / 205
页数:5
相关论文
共 17 条
[1]   Saphenous vein versus polytetrafluoroethylene carotid patch angioplasty [J].
Allen, PJ ;
Jackson, MR ;
ODonnell, SD ;
Gillespie, DL .
AMERICAN JOURNAL OF SURGERY, 1997, 174 (02) :115-117
[2]   FIBRIN SEALANT - SUMMARY OF A CONFERENCE ON CHARACTERISTICS AND CLINICAL USES [J].
ALVING, BM ;
WEINSTEIN, MJ ;
FINLAYSON, JS ;
MENITOVE, JE ;
FRATANTONI, JC .
TRANSFUSION, 1995, 35 (09) :783-790
[3]  
AOKI N, 1985, FACTOR 13 FIBRONECTI, P205
[4]  
Dickneite G, 1998, THROMB HAEMOSTASIS, V80, P192
[5]   EFFECTS OF CROSSLINKING ON THE RIGIDITY AND PROTEOLYTIC SUSCEPTIBILITY OF HUMAN FIBRIN CLOTS [J].
GLADNER, JA ;
NOSSAL, R .
THROMBOSIS RESEARCH, 1983, 30 (03) :273-288
[6]   Fibrin sealant: Current and potential clinical applications [J].
Jackson, MR ;
MacPhee, MJ ;
Drohan, WN ;
Alving, BM .
BLOOD COAGULATION & FIBRINOLYSIS, 1996, 7 (08) :737-746
[7]   Reduction in requirements for allogeneic blood products: Pharmacologic methods [J].
Janssens, M ;
Hartstein, G ;
David, JL .
ANNALS OF THORACIC SURGERY, 1996, 62 (06) :1944-1950
[8]   The role of fibrin tissue adhesives in surgery of haemophilia patients [J].
Martinowitz, U ;
Varon, D ;
Heim, M .
HAEMOPHILIA, 1998, 4 (04) :443-448
[9]   4 YEARS EXPERIENCE WITH FIBRIN SEALANT IN THORACIC AND CARDIOVASCULAR-SURGERY [J].
MATTHEW, TL ;
SPOTNITZ, WD ;
KRON, IL ;
DANIEL, TM ;
TRIBBLE, CG ;
NOLAN, SP .
ANNALS OF THORACIC SURGERY, 1990, 50 (01) :40-44
[10]   A randomised trial of fibrin sealant in peripheral vascular surgery [J].
Milne, AA ;
Murphy, WG ;
Reading, SJ ;
Ruckley, CV .
VOX SANGUINIS, 1996, 70 (04) :210-212